Profil
Sarah Connors worked as a Media Contact at AMAG Pharmaceuticals, Inc. and as a Vice President-Corporate Communications at Karyopharm Therapeutics, Inc.
Ehemalige bekannte Positionen von Sarah Connors
Unternehmen | Position | Ende |
---|---|---|
KARYOPHARM THERAPEUTICS INC. | Public Communications Contact | 01.03.2023 |
AMAG PHARMACEUTICALS, INC. | Public Communications Contact | 01.06.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |